Cymbalta vs. Pristiq

See how Cymbalta and Pristiq compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Cymbalta and Pristiq are both SNRIs used for depression, but Cymbalta is also approved for anxiety and several chronic pain conditions, while Pristiq's approval is limited to major depressive disorder in adults.

  • Cymbalta requires a titration schedule moving from 30 mg to 60 mg daily, while Pristiq is typically prescribed at a single 50 mg dose with no titration needed.

  • Both drugs share nausea and dizziness as common side effects, but Pristiq's nausea rate (up to 41%) runs notably higher than Cymbalta's (up to 30%).

Cymbalta vs. Pristiq Drug Summary

Cymbalta

Cymbalta (duloxetine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) that treats depression, anxiety, and chronic pain conditions like diabetic nerve pain and fibromyalgia. It comes as a delayed-release capsule, with the dose increased gradually from 30 mg to 60 mg daily.

Pristiq

Pristiq (desvenlafaxine) is an SNRI approved specifically for major depressive disorder in adults, without Cymbalta's broader pain approvals. It comes as an extended-release tablet taken once daily at a fixed 50 mg dose, with no titration needed.

Cymbalta vs. Pristiq Side Effects

Cymbalta

Most common
nausea (up to 30%)
dizziness (up to 17%)
somnolence (up to 21%)
headache (up to 18%)

Pristiq

Most common
nausea (up to 41%)
dizziness (up to 16%)
dry mouth (up to 25%)
constipation (up to 14%)

Cymbalta vs. Pristiq Dosage

Cymbalta

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 30 mg once daily Week 1
Maximum dose 60 mg once daily Week 2 onward
Dose changes 1 increase Every week

Pristiq

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 50 mg once daily Day 1 onward
Maximum dose 50 mg once daily Same as starting
Dose changes None Fixed dose

Cymbalta vs. Pristiq Indications

Cymbalta

Cymbalta is FDA-approved for major depressive disorder, generalized anxiety disorder, and several chronic pain syndromes, making it one of the few antidepressants with pain-specific approvals. This dual action can help patients managing both mood symptoms and physical pain with a single medication.

  • Major depressive disorder

  • Generalized anxiety disorder

  • Diabetic peripheral neuropathic pain

  • Fibromyalgia

Pristiq

Pristiq is FDA-approved only for major depressive disorder in adults, with no anxiety or pain indications. It offers a simpler treatment profile focused solely on mood symptoms, using a single standard dose for most patients.

  • Major depressive disorder in adults

  • 50 mg once daily is both the starting and target dose

  • Not approved for anxiety, chronic pain, or pediatric use

  • Higher doses showed no added efficacy benefit

Cymbalta vs. Pristiq Pros and Cons

Cymbalta

Cymbalta's approval for chronic pain conditions alongside depression and anxiety gives it broader clinical use than many SNRIs. That flexibility comes with a more involved titration process and stricter warnings around liver and kidney function.

Pros

  • FDA-approved for chronic pain conditions like diabetic neuropathy and fibromyalgia, not just depression

  • Long-standing safety record, approved since 2004

  • Dosing can be split twice daily for patients sensitive to peak-level side effects

  • Broader indication list allows treating overlapping mood and pain symptoms with one drug

Cons

  • Requires several weeks of titration before reaching the maintenance dose

  • Must be avoided entirely in patients with liver disease or severe kidney impairment

  • More complex dosing options at higher doses may reduce adherence

  • Metabolized by CYP1A2 and CYP2D6, raising interaction risk with certain drugs

Pristiq

Pristiq's single fixed dose makes it simpler to start and manage than many SNRIs, but its FDA approval is limited strictly to depression. As the active metabolite of venlafaxine, it may suit patients who previously responded to Effexor.

Pros

  • Single fixed dose (50 mg) simplifies treatment without titration

  • Active metabolite of venlafaxine, may suit patients who tolerated Effexor

  • Generic desvenlafaxine available, lowering cost compared to brand-name Pristiq

  • Simpler side-effect monitoring with no dose-related adjustments needed

Cons

  • Approved only for adult depression, not anxiety or chronic pain

  • Higher doses show no added benefit, limiting options for partial responders

  • No established use for anxiety, pain, or other off-label conditions common with SNRIs

  • Requires dose adjustment in kidney impairment rather than simple avoidance

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.